Clinical Trial Update: Clinical Study Evaluating the Safety, Tolerability, and Preliminary Efficacy of LM-108 ± Penpulimab+Chemotherapy in Advanced Solid Tumors - Cohort C [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/2 study evaluating LM-108 with Penpulimab and chemotherapy in patients with advanced pancreatic cancer, currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Chemotherapy (chemotherapy)
• LM-108
• Penpulimab

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Advanced Pancreatic Cancer | Phase 1, Phase 2 | Status: RECRUITING